United States · Venture startup
6 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$209Mraised across 6 rounds since 2003, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by sec.govSEC filing: $7.5M sold, first sale May 2011
No investor was named in the report.
From a historical funding recordSEC filing: $61M sold, first sale Nov 2010
No investor was named in the report.
Reported by fiercebiotech.comSEC filing: $30M sold, first sale Mar 2009
Greylock
Venrock
Highland Capital Partners
MPM Capital
Prospect Venture PartnersFrom a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
VenrockGreylockHighland Capital PartnersMPM Capital
Hercules CapitalOxford Bioscience PartnersProspect Venture PartnersFlagship VenturesFrom historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
AVEO Pharmaceuticals's investors include Venrock, Greylock, Highland Capital Partners, MPM Capital and Hercules Capital, and 3 more on record.
AVEO Pharmaceuticals has raised $209M across 6 rounds since 2003.
AVEO Pharmaceuticals's most recent round was a Venture of $7.5M in May 2011.
AVEO Pharmaceuticals's largest round on record is $61M (Venture), in Nov 2010.
AVEO Pharmaceuticals's first round on record, in Oct 2003, was backed by Greylock, Venrock and Highland Capital Partners and 4 others.
AVEO Pharmaceuticals's latest named round is a Venture, in May 2011.
AVEO Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·